IDXX

IDEXX Laboratories, Inc.

Healthcare
538.99 -6.17 -1.13% Pre-Market
2026-09-02 • USD

Key Metrics

Market Cap 42.46B
EV 42.84B
Shares Out 78.78M
Revenue (ttm) 4.55B
Net Income 1.14B
Beta —
P/E —
Forward P/E —
EPS (ttm) $14.23
P/S 9.35
P/B 26.39
P/FCF 33.93
P/C 31.03
EV/Sales 9.41
EV/EBITDA 26.65
ROA 33.38%
ROE 71.82%
ROIC 53.3%
Gross Margin 62.45%
Oper. Margin 32.03%
Profit Margin 25.03%
Debt/Eq 0.36
LT Debt/Cap 15.68%
Quick Ratio 0.64
Current Ratio 1.17
Book/sh 20.42
Cash/sh 2.49
Div Yield —
Div TTM —
Payout Ratio —
SMA20 -3.89%
SMA50 -3.57%
SMA200 -11.44%
Volume 655,414
Avg Volume 634.93K
Rel Volume 1.03
Perf Week 0.01%
Perf Month -3.99%
Perf Quarter -2.78%
Perf Half Y -14.22%
Perf YTD -19.42%
Perf Year -14.01%
Perf 3Y 6.62%
Perf 5Y -20.80%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

IDEXX Laboratories, Inc. is a global diagnostics and software company serving veterinary healthcare, water microbiology and livestock and poultry diagnostics markets. The company…

Name
IDEXX Laboratories, Inc.
Industry
Diagnostics & Research
CEO
Jonathan J. Mazelsky · President and Chief Executive Officer
Employees
—
IPO Date
2014-11-19
Phone
(207) 556-0300
Address
One IDEXX Drive, Westbrook, ME 04092
Website
www.idexx.com

Key Executives

Name Title FY Pay
Jay Mazelsky President and CEO (Current as of filing date) —
Annette Catino Chief Financial Officer —
Sharon E. Underberg Executive Vice President, General Counsel and Corporate Secretary —
Michael G. Erickson, PhD Chief Innovation Officer and President, Companion Animal Group Diagnostics —
Jonathan J. Mazelsky President and Chief Executive Officer —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.